Medical News / Broadcasting from AAAAI 2021 Congress: Managing Asthmatic Fears During COVID-19

As covered by Lakiea Wright, MD, in a previous interview segment with HCPLive® during the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions, a series of new studies presented at the annual meeting this weekend indicated the association between COVID-19 risk and asthma status may be specific to differing phenotypes, treatment regimens, and biomarkers. In the second segment of her AAAAI 2021 discussion with HCPLive, Wright, from Brigham and Women’s Hospital and Thermo Fisher Scientific, explained what clinicians should contrive from this newest research in navigating asthmatic patient concerns during the pandemic. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

MORE MEDICAL NEWS
Omalizumab (Xolair) benefitted sleep disturbance among patients with nasal polyposis over a span of 76 weeks, ... read more
A collection of articles published at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 ... read more
At the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this weekend, a ... read more
New research shows a recently revised diagnostic criteria is sufficient for emergency departments to identify and ... read more